Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
How Long Do People Live When Cancer Spreads to the Bones?
How Long Do People Live When Cancer Spreads to the Bones? 2

When cancer spreads to the bones, it’s a big change. This is called bone metastases or metastatic bone cancer. It happens when cancer cells from another part of the body reach the bones.

The most common cancers that spread to the bones are breast, prostate, lung, and thyroid cancers.

At Liv Hospital, we know how tough this stage can be. We offer top-notch care and support. The chance of living longer with bone stage 4 cancer depends on several things.

These include the type of cancer, your overall health, and how much the bones are affected.

Key Takeaways

  • Understanding bone metastases and its impact on survival rates.
  • Common primary cancers that lead to metastatic bone cancer.
  • The importance of overall health in determining prognosis.
  • State-of-the-art guidance and support for patients and families.
  • Factors influencing survival rates for individuals with bone stage 4 cancer.

What Are Bone Metastases?

A detailed cross-section of human bone structure
How Long Do People Live When Cancer Spreads to the Bones? 3

Bone metastases occur when cancer cells from another part of the body move to the bones. This makes treating cancer harder and affects the patient’s life quality.

Definition and Terminology

Bone metastases, also known as secondary bone cancer or mets cancer, happen when cancer cells move to the bones. It’s different from primary bone cancer, which starts in the bones. Knowing the terms helps patients understand their condition and treatment.

How Cancer Spreads to Bones

Cancer cells break off from the main tumor, enter the blood or lymph, and settle in the bones. The spine, pelvis, ribs, and long bones are often affected.

For more info on metastatic cancer, check out OncoDaily’s blog on Metastatic Breast Cancer Day.

Common Sites of Bone MetastasesSymptoms
SpineBack pain, neurological symptoms
PelvisPain in the hip or groin
RibsChest pain, difficulty breathing
Long bones (arms and legs)Pain, risk of fractures

Understanding bone metastases is key to managing it and improving life for cancer patients. The process of cancer spreading to bones is complex. Knowing common sites and symptoms helps in early detection and treatment.

Common Types of Cancer with Bone Metastases

cross-section of bone metastases
How Long Do People Live When Cancer Spreads to the Bones? 4

Breast, prostate, lung, and thyroid cancers often spread to the bones. Each cancer type has its own challenges. Knowing how these cancers spread to the bones is key to better treatment.

Breast Cancer

Breast cancer is a top cancer to spread to the bones. About 70% of advanced breast cancer patients get bone metastases. This can cause a lot of pain, fractures, and high calcium levels.

Research shows early treatment of bone metastases in breast cancer is vital. Using drugs like bisphosphonates and denosumab can help prevent bone problems.

Prostate Cancer

Prostate cancer also often spreads to the bones. The Alliance for Clinical Trials in Oncology is starting a new trial. It will look at adding chemotherapy to current treatments for prostate cancer with bone metastases.

Bone metastases in prostate cancer can make bones denser. But, this can also cause pain and fractures.

Lung Cancer

Lung cancer, mainly non-small cell lung cancer (NSCLC), often goes to the bones. About 30-40% of NSCLC patients get bone metastases. This is linked to a poor outlook and a lot of suffering.

New treatments like targeted and immunotherapies have helped lung cancer patients with bone metastases. But, managing bone metastases is a big part of their care.

Thyroid Cancer

Thyroid cancer, though rarer, can also spread to the bones. Some thyroid cancers, like follicular and papillary, are more likely to do so.

Treating bone metastases in thyroid cancer needs a team effort. This includes surgery, radioactive iodine, and radiation therapy.

Cancer TypeFrequency of Bone MetastasesCommon Complications
Breast CancerApproximately 70%Bone pain, fractures, hypercalcemia
Prostate CancerCommon, exact frequency variesBone pain, fractures, urinary retention
Lung CancerApproximately 30-40%Bone pain, fractures, spinal cord compression
Thyroid CancerLess common, varies by typeBone pain, fractures, hypercalcemia

Recognizing Bone Metastases Symptoms

It’s key to spot the signs of bone metastases early. This helps manage the condition better and improves patient outcomes. Bone metastases happen when cancer cells move from their original place to the bones. This leads to several complications.

Bone Pain and Fractures

Bone pain is a common symptom of bone metastases. This pain can last a long time and get worse. It’s caused by cancer cells damaging the bone tissue, leading to pain.

In some cases, the bone gets so weak it breaks, known as a pathological fracture. These fractures can happen without a big injury. This is because the cancer cells weaken the bone structure.

High Calcium Levels and Other Symptoms

Bone metastases can also cause high calcium levels in the blood, or hypercalcemia. This happens when cancer cells release substances that make bones release calcium into the blood. Symptoms of hypercalcemia include confusion, weakness, and constipation.

Other symptoms of bone metastases include:

  • Weakness or numbness in the arms or legs if the spine is affected
  • Fatigue or general feeling of being unwell
  • Loss of appetite or weight loss

Patients with advanced cancer should know these symptoms and tell their healthcare provider right away. Spotting and managing bone metastases symptoms early can greatly improve a patient’s quality of life.

Diagnosis of Metastatic Bone Cancer

To diagnose metastatic bone cancer, doctors use imaging tests, biopsy, and blood tests. It’s key to know how far the cancer has spread. This helps choose the best treatment.

Imaging Tests

Imaging tests are very important in finding bone metastases. They let us see the bones and find any problems.

Types of Imaging Tests

We use different imaging tests, like:

  • X-rays: To spot bone lesions and fractures.
  • Bone scans: To find areas where bone activity is high.
  • CT scans: To get detailed pictures of bones and tissues around them.
  • MRI scans: To see how far bone metastases have spread and their effect on tissues.
  • PET scans: To check how active bone lesions are.

Biopsy and Blood Tests

Biopsy and blood tests are also key for diagnosing metastatic bone cancer.

Biopsy

A biopsy takes a bone tissue sample for testing. It confirms if cancer cells are in the bones.

Blood Tests

Blood tests can find markers for bone metastases. These include high calcium levels or certain tumor markers.

Diagnostic MethodPurpose
X-raysIdentify bone lesions and fractures
Bone scansDetect areas of increased bone activity
CT scansProvide detailed images of bones and surrounding tissues
MRI scansAssess the extent of bone metastases and their impact on surrounding tissues
PET scansEvaluate the metabolic activity of bone lesions
BiopsyConfirm the presence of cancer cells in the bones
Blood testsIdentify markers associated with bone metastases

Survival Rates for Breast Cancer with Bone Metastases

Knowing survival rates is key for breast cancer patients with bone metastases. When breast cancer reaches the bones, it changes the patient’s outlook and treatment. We’ll look at the median survival time and what affects it.

Median Survival Time

The time left after breast cancer spreads to bones varies. Studies show that patients live about 27 months on average. But, this time can change a lot. It depends on the patient’s health, how much bone is involved, and how well treatment works.

Factors Affecting Prognosis

Many things can change how long a patient might live. These include:

  • The number and location of bone metastases
  • The presence of additional organ metastases
  • The patient’s age and overall health
  • The hormone receptor status of the tumor
  • The response to initial treatment

We look at these factors to plan the best treatment. This way, doctors can give patients with bone metastases more tailored care and support.

Survival Rates for Prostate Cancer with Bone Metastases

When prostate cancer spreads to the bones, knowing survival rates is key. This stage affects a patient’s life quality and treatment plans.

Median Survival Time

The median survival time after bone metastasis is a key measure. Studies show it’s about 25 months for prostate cancer patients. But, it can change based on health, bone involvement, and treatment response.

Clinical trials, like the ASPIRE trial, are looking at adding chemotherapy. They help us understand how treatments can impact survival.

Factors Affecting Prognosis

Several things can change a patient’s outlook with bone metastases. These include:

  • The extent of bone metastasis
  • The presence of other metastatic sites
  • The patient’s overall health and performance status
  • The Gleason score at diagnosis
  • Response to initial hormone therapy

Knowing these factors helps doctors create better treatment plans. This can improve survival chances.

FactorImpact on Prognosis
Extent of Bone MetastasisMore widespread bone involvement generally indicates a poorer prognosis.
Presence of Other Metastatic SitesAdditional metastatic sites can complicate treatment and worsen prognosis.
Patient’s Overall HealthPoor overall health can limit treatment options and affect survival.

By looking at these factors and using clinical trial data, doctors can give better care. This is for prostate cancer patients with bone metastases.

Survival Rates for Lung Cancer with Bone Metastases

Knowing the survival rates for lung cancer with bone metastases is key for patients and doctors. Lung cancer that spreads to bones is advanced. It needs a detailed treatment plan.

Median Survival Time

The median survival time for lung cancer with bone metastases is about 6–7 months. But, this can change a lot based on different things.

Research shows that survival can depend on treatment success and the patient’s health. Early detection and proper care can help improve life quality and maybe extend life.

Factors Affecting Prognosis

Important factors that influence prognosis include:

  • The number of bone metastases
  • The presence of other organ metastases
  • The patient’s overall health and performance status
  • The effectiveness of the treatment regimen

We know each patient’s case is different, and prognosis can vary a lot. It’s vital for patients to talk with their healthcare team about their situation. This way, they can understand their prognosis and treatment choices.

By knowing these factors and working with healthcare providers, patients can make better choices about their care. This can help improve their outcomes.

Can Early-Stage Cancers Spread to Bones?

Bone metastases can happen even when cancer is caught early. This is a big worry for both patients and doctors. Knowing the risks and what it means is key to fighting the disease well.

Stage 1 Breast Cancer and Bone Metastasis Risk

Stage 1 breast cancer means the tumor is small and hasn’t spread to lymph nodes. While bone metastases are less common, some things can raise the risk. These include fast-growing tumors or those with specific markers.

Key factors that may increase the risk of bone metastases in stage 1 breast cancer include:

  • Tumor size and grade
  • Hormone receptor status
  • HER2 status
  • Presence of lymphovascular invasion

Other Early-Stage Cancers

Not just breast cancer can spread to bones. Prostate, lung, and thyroid cancers can too. The risk factors for these cancers are similar, like tumor biology and stage.

It’s essential for patients with early-stage cancer to discuss their individual risk factors with their healthcare provider. They need to know about their cancer’s specific traits and how they might affect bone metastasis risk.

By knowing these risks and working with their healthcare team, patients can get the right care. This can help lower the chance of problems from bone metastases.

Types of Bone Metastases and Their Impact

Bone metastases can be divided into different types based on their effects on bone tissue. Knowing these types helps doctors choose the right treatment and manage symptoms better.

Osteoblastic Metastases

Osteoblastic metastases involve the abnormal growth of bone tissue around cancer cells. This is common in prostate cancer. The cancer makes bones denser, but these bones are weak and can cause pain and fractures.

These metastases can greatly affect a patient’s life. A full treatment plan is needed, including pain relief and treatments to prevent bone fractures.

Osteolytic Lesions

Osteolytic lesions destroy bone tissue. They are often linked to breast cancer and lung cancer. Cancer cells break down bones, leading to pain and a higher risk of fractures.

Patients with osteolytic lesions need close monitoring and treatment. This includes medicines to strengthen bones and manage pain and other symptoms.

In summary, the type of bone metastasis greatly affects treatment and patient outcomes. Knowing whether a patient has osteoblastic or osteolytic lesions helps doctors tailor treatments. This improves the patient’s quality of life.

Factors Influencing Survival with Cancer with Bone Metastases

Bone metastases in cancer patients make their outlook more complex. Several factors affect their survival. We will dive into these to grasp their impact.

Number of Bone Lesions

The extent of bone involvement is key in survival prediction. Research indicates that more bone lesions lead to a worse prognosis. The number of bone metastases greatly affects survival rates, with more disease linked to shorter lives.

Presence of Additional Organ Metastases

Metastases in other organs, along with bone, complicate the situation. Patients with metastases in multiple organs face a poorer prognosis than those with bone metastases only. This is because widespread disease often signals a more aggressive cancer.

FactorImpact on Survival
Number of Bone LesionsHigher number of lesions = poorer prognosis
Presence of Additional Organ MetastasesMultiple organ metastases = worse prognosis
Response to TreatmentPositive response = improved survival

Response to Treatment

A patient’s response to treatment is a major survival predictor. Those who respond well to therapy tend to live longer. Treatment success depends on the cancer type, disease extent, and individual factors.

Understanding these factors is vital for healthcare providers to create effective treatment plans. It also helps patients set realistic expectations about their prognosis.

Treatment Options and Quality of Life

The main goal in treating bone metastases is to improve the patient’s quality of life. Treatment plans are made just for each person. They take into account the type of cancer, how much bone is involved, and the patient’s health.

Systemic Treatments

Systemic treatments aim to fight cancer that has spread all over the body. These include:

  • Chemotherapy: Drugs that kill cancer cells.
  • Hormone Therapy: Lowering hormones that cancer cells need to grow.
  • Targeted Therapy: Stopping cancer cells from growing by targeting their specific traits.
  • Immunotherapy: Helping the body’s immune system fight cancer.

Local Treatments

Local treatments target cancer in specific bones. They include:

  • Radiation Therapy: Rays that kill cancer cells in bones.
  • Surgery: Operations to stabilize bones or ease pain.

For example, Study 1100 is looking into the safety of NBTXR3 for head and neck cancer. It shows the effort to make local treatments better.

Pain Management

Managing pain is key to a good quality of life. This can involve:

  • Medications: Drugs to relieve pain.
  • Nerve Blocks: Procedures to block pain signals to the brain.

Supportive and Palliative Care

Supportive and palliative care help with the symptoms and stress of serious illness. They include:

  • Symptom Management: Managing symptoms like pain, nausea, and fatigue.
  • Emotional and Spiritual Support: Support for patients and their families.

Healthcare providers use these treatments to improve life for patients with bone metastases. Each plan is unique, based on the patient’s specific needs and situation.

Conclusion

It’s key for patients to understand cancer with bone metastases to make smart care choices. We’ve talked about how cancers like breast, prostate, and lung can spread to bones. This affects survival and quality of life.

The outlook for patients with bone metastases depends on several things. These include the number of bone lesions, if other organs are affected, and how well treatment works. Treatments like systemic and local therapies, pain management, and supportive care help improve life quality.

By grasping the complexities of cancer with bone metastases, patients and doctors can create effective plans. A complete care approach, focusing on treatment and quality of life, is essential. This helps patients get the best support on their journey.

What are bone metastases?

Bone metastases, also known as metastatic bone cancer, happen when cancer cells spread to bones. This can cause many symptoms and problems.

How does cancer spread to bones?

Cancer cells break off from the main tumor and enter the blood or lymph system. They then settle in bone tissue.

What types of cancer commonly spread to bones?

Breast, prostate, lung, and thyroid cancers often spread to bones. Kidney and melanoma cancers can also do this.

What are the symptoms of bone metastases?

Symptoms include bone pain, fractures, and high calcium levels. The severity and type of symptoms depend on where and how much the cancer has spread.

How are bone metastases diagnosed?

Doctors use X-rays, CT scans, MRI scans, and bone scans for diagnosis. They also do biopsies and blood tests to check the disease’s extent.

Can stage 1 breast cancer spread to bones?

Yes, even stage 1 breast cancer can spread to bones. This is more likely if there are other risk factors.

What is the prognosis for patients with bone metastases?

The outlook varies a lot. It depends on the cancer type, how many bones are affected, and how well the cancer responds to treatment.

What are the treatment options for bone metastases?

Treatments include chemotherapy, hormone therapy, and local treatments like radiation and surgery. Pain management and supportive care also help improve life quality.

How do osteoblastic metastases differ from osteolytic lesions?

Osteoblastic metastases are abnormal bone growth, often in prostate cancer. Osteolytic lesions are bone destruction, seen in breast and lung cancers.

What factors influence survival in patients with cancer with bone metastases?

Survival depends on the number of bone lesions, if cancer has spread to other organs, treatment response, and overall health.

Can bone metastases be treated to improve quality of life?

Yes, treatments can manage symptoms, reduce pain, and enhance life quality for those with bone metastases.

What is the median survival time for patients with bone metastases from different cancers?

Survival times vary a lot. They range from a few months for lung cancer to several years for some breast and prostate cancer patients.

How does the presence of additional organ metastases affect prognosis?

Having cancer in other organs usually means a worse prognosis. It shows the disease has spread more widely.

  • American Cancer Society. (n.d.). Survival Statistics for Bone Cancer. Retrieved from https://www.cancer.org/cancer/types/bone-cancer/detection-diagnosis-staging/survival-statistics.html
  • Cancer Research UK. (n.d.). Bone cancer survival statistics. Retrieved from https://www.cancerresearchuk.org/about-cancer/bone-cancer/survival
  • Hui, Z., Yu, B., Xu, J., et al. (2020). Epidemiology, risk factors and clinical management of bone sarcomas. BMC Cancer, 20, 419. PMC7210217. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7210217/
  • National Center for Biotechnology Information (NCBI). (n.d.). Bone Metastasis (StatPearls Publishing). NBK507911. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK507911/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75